Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany - results of the national telephone health interview survey ‘German Health Update (GEDA)’ 2009

BMC Public Health

Christa Scheidt-Nave¹  Patrick Schmich¹  Antje Gößwald¹  Christin Heidemann¹  Yong Du¹ 

[1] Department of Epidemiology and Health Monitoring, Division of Non-Communicable Disease Epidemiology, Robert Koch Institute, General-Pape-Str. 62-66, D-12101, Berlin, Germany

关键词: Germany;    Comorbidity;    Prevalence;    Diabetes;   

Others  :  1162513
DOI  :  10.1186/1471-2458-13-166

 received in 2012-05-29, accepted in 2013-02-08,  发布年份 2013

【 摘 要 】

Background

Despite the major public health impact of diabetes, recent population-based data regarding its prevalence and comorbidity are sparse.

Methods

The prevalence and comorbidity of diabetes mellitus were analyzed in a nationally representative sample (N = 9133) of the non-institutionalized German adult population aged 50 years and older. Information on physician-diagnosed diabetes and 20 other chronic health conditions was collected as part of the national telephone health interview survey ‘German Health Update (GEDA)’ 2009. Overall, 51.2% of contacted persons participated. Among persons with diabetes, diabetes severity was defined according to the type and number of diabetes-concordant conditions: no diabetes-concordant condition (grade 1); hypertension and/or hyperlipidemia only (grade 2); one comorbidity likely to represent diabetes-related micro- or macrovascular end-organ damage (grade 3); several such comorbidities (grade 4). Determinants of diabetes severity were analyzed by multivariable ordinal regression.

Results

The 12-month prevalence of diabetes was 13.6% with no significant difference between men and women. Persons with diabetes had a significantly higher prevalence and average number of diabetes-concordant as well as diabetes-discordant comorbidities than persons without diabetes. Among persons with diabetes, 10.2%, 46.8%, 35.6% and 7.4% were classified as having severity grade 1–4, respectively. Determinants of diabetes severity included age (cumulative odds ratio 1.05, 95% confidence interval 1.03-1.07, per year) and number of discordant comorbidities (1.40, 1.25-1.55). With respect to specific discordant comorbidities, diabetes severity was correlated to depression (2.15, 1.29-3.56), respiratory disease (2.75, 1.72-4.41), musculoskeletal disease (1.53, 1.06-2.21), and severe hearing impairment (3.00, 1.21-7.41).

Conclusions

Diabetes is highly prevalent in the non-institutionalized German adult population 50 years and older. Diabetes comorbidities including diabetes-concordant and diabetes-discordant conditions need to be considered in epidemiological studies, in order to monitor disease burden and quality of diabetes care. Definitional standards of diabetes severity need to be refined and consented.

【 授权许可】

   
2013 Du et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001, 414(6865):782-787.
• [2]Conwell LJ, Boult C: The effects of complications and comorbidities on the quality of preventive diabetes care: a literature review. Popul Health Manag 2008, 11(4):217-228.
• [3]Kerr EA, Heisler M, Krein SL, Kabeto M, Langa KM, Weir D, Piette JD: Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? J Gen Int Med 2007, 22(12):1635-1640.
• [4]World Health Organization: Prevention of diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994, 844:1-100.
• [5]International Diabetes Federation: IDF Diabetes Atlas. 5th edition. Brussels, Belgium: International Diabetes Federation; 2011.
• [6]Stark RG, Schunk MV, Meisinger C, Rathmann W, Leidl R, Holle R, for the KSG: Medical care of type 2 diabetes in German Disease Management Programmes: a population-based evaluation. Diabetes Metab Res Rev 2011, 27(4):383-391.
• [7]Feinstein AR: The pre-therapeutic classification of co-morbidity in chronic disease. J Chron Dis 1970, 23(7):455-468.
• [8]Kaplan MH, Feinstein AR: The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974, 27(7–8):387-404.
• [9]Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M: Defining comorbidity: implications for understanding health and health services. Ann Fam Med 2009, 7(4):357-363.
• [10]Boyd CM, Leff B: Quality of care for older patients with diabetes mellitus with comorbidity. J Am Geriatr Soc 2006, 54(3):553-554.
• [11]Heidemann C, Kroll L, Icks A, Lampert T, Scheidt-Nave C: Prevalence of known diabetes in German adults aged 25–69 years: results from national health surveys over 15 years. Diabet Med 2009, 26(6):655-658.
• [12]Schipf S, Werner A, Tamayo T, Holle R, Schunk M, Maier W, Meisinger C, Thorand B, Berger K, Mueller G: Regional differences in the prevalence of known type 2 diabetes mellitus in 45–74 years old individuals: Results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med 2012, 29(7):e88-e95.
• [13]Köster I, von Ferber L, Ihle P, Schubert I, Hauner H: The cost burden of diabetes mellitus: the evidence from Germany—the CoDiM Study. Diabetologia 2006, 49(7):1498-1504.
• [14]Köster I, Huppertz E, Hauner H, Schubert I: Direct costs of diabetes mellitus in Germany - CoDiM 2000–2007. Exp Clin Endocrinol Diabetes 2011, 119(6):377-385.
• [15]Köster I, Schubert I, Huppertz E: Follow up of the CoDiM-Study: Cost of diabetes mellitus 2000–2009. Dtsch Med Wochenschr 2012, 137(19):1013-1016.
• [16]Hoffmann F, Icks A: Diabetes prevalence based on health insurance claims: large differences between companies. Diabet Med 2011, 28(8):919-923.
• [17]Pittrow D, Stalla G, Zeiher A, Silber S, März W, Pieper L, Klotsche J, Glaesmer H, Ruf G, Schneider H: Prävalenz, medikamentöse Behandlung und Einstellung des Diabetes mellitus in der Hausarztpraxis*. Med Klin Intensivmed Notfallmed 2006, 101(8):635-644.
• [18]Liebl A, Neiss A, Spannheimer A, Reitberger U, Wieseler B, Stammer H, Goertz A: Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany–results from the CODE-2 study. Exp Clin Endocrinol Diabetes 2002, 110(1):10-16.
• [19]Fuchs J, Busch M, Lange C, Scheidt-Nave C: Prevalence and patterns of morbidity among adults in Germany. Results of the German telephone health interview survey German Health Update (GEDA) 2009. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012, 55(4):576-586.
• [20]van den Bussche H, Koller D, Kolonko T, Hansen H, Wegscheider K, Glaeske G, von Leitner EC, Schafer I, Schon G: Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. BMC Public Health 2011, 11:101. BioMed Central Full Text
• [21]Schafer I, Hansen H, Schon G, Hofels S, Altiner A, Dahlhaus A, Gensichen J, Riedel-Heller S, Weyerer S, Blank W: The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. first results from the multicare cohort study. BMC Health Serv Res 2012, 12(1):89. BioMed Central Full Text
• [22]Koch-Institut R: Daten und Fakten: Ergebnisse der Studie 'Gesundheit in Deutschland aktuell 2009'. Berlin: Robert Koch Institut; 2011.
• [23]Gabler S, Häder S: Idiosyncrasies in telephone sampling-The case of Germany. Int J Public Opin Res 2002, 14(3):339-345.
• [24]Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. Revised 2009. http://www.aapor.org/AM/Template.cfm?Section=Standard_Definitions%20&Template=/CM/ContentDisplay.cfm&ContentID=1819 webcite.
• [25]Robine J-M, Jagger C, Group TE-R: Creating a coherent set of indicators to monitor health across Europe. Euro J Public Health 2003, 13(suppl 1):6-14.
• [26]Piette JD, Kerr EA: The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006, 29(3):725-731.
• [27]WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363(9403):157-163.
• [28]Müller W, Lüttinger P, König W, Karle W: Class and education in industrial nations. Int J Sociol 1989, 19:36.
• [29]Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA: National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378(9785):31-40.
• [30]Danaei G, Friedman AB, Oza S, Murray CJ, Ezzati M: Diabetes prevalence and diagnosis in US states: analysis of health surveys. Popul Health Metr 2009, 7:16. BioMed Central Full Text
• [31]Brown AF, Ettner SL, Piette J, Weinberger M, Gregg E, Shapiro MF, Karter AJ, Safford M, Waitzfelder B, Prata PA: Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev 2004, 26(1):63-77.
• [32]Hoffmann F, Icks A: Diabetes 'epidemic' in Germany? A critical look at health insurance data sources. Exp Clin Endocrinol Diabetes 2012, 120(7):410-415.
• [33]Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE: Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care 2010, 33(3):562.
• [34]Bonaldi C, Vernay M, Roudier C, Salanave B, Oleko A, Malon A, Castetbon K, Fagot-Campagna A: A first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals: the French Nutrition and Health Survey 2006/2007. Diabet Med 2011, 28(5):583-589.
• [35]Imkampe AK, Gulliford MC: Increasing socio-economic inequality in type 2 diabetes prevalence–repeated cross-sectional surveys in England 1994–2006. Eur J Public Health 2011, 21(4):484-490.
• [36]Fowler MJ: Microvascular and macrovascular complications of diabetes. Clin Diab 2008, 26(2):77-82.
• [37]Zhang X, Gregg EW, Cheng YJ, Thompson TJ, Geiss LS, Duenas MR, Saaddine JB: Diabetes mellitus and visual impairment: National health and nutrition examination survey, 1999–2004. Arch Ophthalmol 2008, 126(10):1421-1427.
• [38]Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW, Albright AL, Klein BEK, Klein R: Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010, 304(6):649-656.
• [39]Augood CAVJ, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Bentham G, Rahu M, Vioque J, Young IS, Fletcher AE: Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 2006, 124(4):529-535.
• [40]Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R: Retinopathy in diabetes. Diabetes Care 2004, 27(suppl 1):s84-s87.
• [41]Picardi A, D'Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S, Afeltra A: Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev 2006, 22(4):274-283.
• [42]Li C, Balluz LS, Ford ES, Okoro CA, Tsai J, Zhao G: Association between diagnosed diabetes and self-reported cancer among U.S. adults: findings from the 2009 Behavioral Risk Factor Surveillance System. Diabetes Care 2011, 34(6):1365-1368.
• [43]Berenbaum F: Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Ann Rheum Dis 2011, 70(8):1354-1356.
• [44]Sturmer T, Brenner H, Brenner RE, Gunther KP: Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm osteoarthritis study. Scand J Rheumatol 2001, 30(3):169-171.
• [45]Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D: Diabetes and cancer: a consensus report. Diabetes Care 2010, 33(7):1674-1685.
• [46]Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, Shan J, Ferrara A: Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010, 33(1):55-60.
• [47]Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, Colditz GA, Speizer FE, Barr RG, Camargo CA Jr: Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004, 27(10):2478-2484.
• [48]Polyzos SA, Kountouras J, Zavos C, Deretzi G: The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 2011, 16(2):79-88.
• [49]Mitchell P, Gopinath B, McMahon CM, Rochtchina E, Wang JJ, Boyages SC, Leeder SR: Relationship of type 2 diabetes to the prevalence, incidence and progression of age-related hearing loss. Diabet Med 2009, 26(5):483-488.
• [50]Stuart MJ, Baune BT: Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev 2012, 36(1):658-676.
• [51]Liebl A, Spannheimer A, Reitberger U, Gortz A: Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study. Med Klin 2002, 97(12):713-719. Munich
• [52]Morgan CL, Currie CJ, Stott NC, Smithers M, Butler CC, Peters JR: The prevalence of multiple diabetes-related complications. Diabet Med 2000, 17(2):146-151.
• [53]Morgan CL, Peters JR, Currie CJ: The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK. Diabet Med 2010, 27(6):673-678.
• [54]Parmelee PA, Thuras PD, Katz IR, Lawton MP: Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc 1995, 43(2):130-137.
• [55]Linn BS, Linn MW, Gurel L: Cumulative illness rating scale. J Am Geriatr Soc 1968, 16(5):622-626.
• [56]Nemeroff CB: The curiously strong relationship between cardiovascular disease and depression in the elderly. Am J Geriatr Psychiatry 2008, 16(11):857-860.
• [57]Bourdin A, Burgel PR, Chanez P, Garcia G, Perez T, Roche N: Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Eur Respir Rev 2009, 18(114):198-212.
• [58]Singh G, Miller JD, Lee FH, Pettitt D, Russell MW: Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. Am J Manag Care 2002, 8(15 Suppl):S383-S391.
• [59]Naranjo A, Sokka T, Descalzo M, Calvo-Alén J, Hørslev-Petersen K, Luukkainen R, Combe B, Burmester G, Devlin J, Ferraccioli G: Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 2008, 10(2):1-10. BioMed Central Full Text
• [60]Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L: Aging with multimorbidity: A systematic review of the literature. Ageing Res Rev 2011, 10(4):430-439.
• [61]Kakarlapudi V, Sawyer R, Staecker H: The effect of diabetes on sensorineural hearing loss. Otol Neurotol 2003, 24(3):382-386.
• [62]Li C, Balluz LS, Ford ES, Okoro CA, Zhao G, Pierannunzi C: A comparison of prevalence estimates for selected health indicators and chronic diseases or conditions from the Behavioral Risk Factor Surveillance System, the National Health Interview Survey, and the National Health and Nutrition Examination Survey, 2007–2008. Prev Med 2012, 54(6):381-387.
• [63]Turner EL, Lane JA, Donovan JL, Davis MJ, Metcalfe C, Neal DE, Hamdy FC, Martin RM: Association of diabetes mellitus with prostate cancer: nested case–control study (Prostate testing for cancer and treatment study). Int J Cancer 2011, 128(2):440-446.
• [64]Pohar S, Johnson J: Health care utilization and costs in Saskatchewan's registered Indian population with diabetes. BMC Health Serv Res 2007, 7(1):126. BioMed Central Full Text
• [65]Molenaar EA, Ameijden EJCV, Grobbee DE, Numans ME: Comparison of routine care self-reported and biometrical data on hypertension and diabetes: results of the Utrecht Health Project. Euro J Public Health 2007, 17(2):199-205.